• Plk1 Phosphorylation of p31comet Controls Mitotic Checkpoint

  2026-07-14

  This study uncovers how Polo-like kinase 1 (Plk1) directly regulates p31comet function via phosphorylation at S102, suppressing its ability to disassemble mitotic checkpoint complexes (MCC). These findings clarify a key mechanism safeguarding mitotic fidelity and provide a foundation for further exploration of cell cycle control and genome stability.

• Translational Leverage: Mechanistic Insight via DiscoveryPro

  2026-07-14

  This thought-leadership article explores how the DiscoveryProbe™ Bioactive Compound Library Plus (SKU: L1022P) transforms translational research by bridging high-throughput screening with mechanistic discovery. Integrating recent advances in ligand screening, particularly thermal shift assays, and contextualizing the library within the competitive landscape, it offers actionable guidance for researchers targeting complex biological pathways, including apoptosis and PI3K/Akt/mTOR signaling. The discussion highlights strategic workflows, protocol parameters, and the unique translational power of this resource, while acknowledging both maturity and limitations for cross-domain applications.

• G-15: A G Protein-Coupled Estrogen Receptor Antagonist in Ne

  2026-07-13

  G-15 enables precise dissection of GPR30-mediated pathways, uniquely supporting both cellular and in vivo models of estrogen signaling. Its selectivity and robust pharmacology streamline workflows in pain, neurobiology, and immune modulation, as demonstrated by its pivotal role in recent neuropathic pain research.

• Resolving Assay Challenges with Cy5 Goat Anti-Mouse IgG (H+L

  2026-07-13

  This article addresses practical workflow hurdles faced in cell-based immunoassays and demonstrates how the Cy5 Goat Anti-Mouse IgG (H+L) Antibody (SKU K1210) from APExBIO offers proven solutions. Through scenario-driven analysis rooted in recent literature and validated protocols, researchers gain actionable insights into optimizing sensitivity, reproducibility, and reliability in mouse IgG detection.

• L. plantarum P101 Attenuates Alcoholic Steatosis via AMPK Pa

  2026-07-12

  This study demonstrates that Lactiplantibacillus plantarum P101 significantly reduces alcohol-induced hepatic lipid accumulation in mice by activating the AMPK signaling pathway. Using targeted AMPK inhibition, the research clarifies the mechanistic link between probiotic intervention, gut microbiota modulation, and hepatic metabolic regulation, providing an experimental foundation for future strategies in alcoholic fatty liver disease management.

• MAPK Regulators of ECM Internalisation Drive Cancer Invasion

  2026-07-10

  Martinez et al. (2024) developed a high-content screening assay to uncover novel kinase regulators of extracellular matrix (ECM) internalisation in invasive carcinoma cells. They identified the α2β1 integrin/p38 MAPK axis as a critical driver of ECM endocytosis and cell migration, with implications for understanding and targeting cancer invasiveness.

• High Viscosity Drives Chemoresistance via P-gp Upregulation

  2026-07-09

  This study reveals that high extracellular fluid viscosity in the tumor microenvironment promotes chemoresistance in cancer cells by upregulating P-glycoprotein (P-gp) through a mechanobiological signaling cascade. The findings highlight mechanical cues as critical regulators of drug resistance and suggest new avenues for overcoming transporter-mediated chemoresistance.

• Difloxacin HCl: Mechanistic Insights for Next-Generation Ant

  2026-07-09

  Explore the scientific foundation and innovative applications of Difloxacin HCl, a quinolone antimicrobial antibiotic, in advanced susceptibility testing and multidrug resistance research. This article uniquely bridges mechanistic understanding with assay optimization for research excellence.

• Docetaxel (SKU A4394): Practical Answers for Reliable Assays

  2026-07-08

  This article delivers scenario-driven, evidence-backed guidance for applying Docetaxel (SKU A4394) in cancer cell viability, proliferation, and cytotoxicity workflows. Drawing on peer-reviewed research and product data, it addresses common laboratory challenges and positions APExBIO's Docetaxel as a robust solution for reproducible oncology assays.

• DiscoveryProbe FDA-approved Drug Library: Evidence, Action,

  2026-07-08

  The DiscoveryProbe FDA-approved Drug Library (SKU: L1021) is a rigorously curated set of 2,320 clinically approved bioactive compounds. This library accelerates drug repositioning screening and pharmacological target identification by providing pre-dissolved, mechanism-diverse molecules for high-throughput and high-content assays.

• Tiamulin (Thiamutilin): Bridging Antibacterial and Anti-Infl

  2026-07-07

  This thought-leadership article delivers an advanced, evidence-driven exploration of Tiamulin (Thiamutilin) as both a veterinary antibiotic and a dual-action research tool for translational applications. We integrate mechanistic, pharmacokinetic, and workflow insights—anchored by recent metabolomics and signaling studies—to guide translational researchers seeking to leverage its unique antibacterial and anti-inflammatory properties. This piece moves beyond standard product descriptions, offering a strategic roadmap for experimental optimization and domain-bridging innovation.

• DiscoveryProbe Bioactive Compound Library Plus: Mechanisms a

  2026-07-07

  The DiscoveryProbe Bioactive Compound Library Plus offers 5,072 cell-permeable bioactive compounds for pathway analysis and high-throughput screening. Its rigorous quality control and coverage of diverse targets support advanced cancer and immunology research. Evidence-backed protocols and clear boundaries distinguish its optimal use.

• Linoleic Acid (C18:2(9Z,12Z)): Technical Use and Workflow Gu

  2026-07-06

  Linoleic Acid (C18:2(9Z,12Z)) is essential for modeling oxidative stress, membrane fluidity, and essential fatty acid deficiency in cell-based and animal protocols where aqueous solubility is not required. It should not be used in workflows needing stable, long-term stock solutions or direct water solubilization. This guide details actionable parameters, workflow design, and troubleshooting for research applications.

• Applied Workflows with Doxorubicin Hydrochloride in Cancer R

  2026-07-06

  Doxorubicin hydrochloride (Adriamycin HCl) empowers cutting-edge cancer chemotherapy research by enabling precise DNA damage and cardiotoxicity modeling. This article delivers actionable, evidence-backed workflows and troubleshooting insights, ensuring reproducibility and data integrity across both cellular and in vivo studies.

• NU7441 (KU-57788) in DNA Repair Research: Protocols & Insigh

  2026-07-05

  NU7441 (KU-57788) is redefining DNA repair and oncology research by enabling sensitive, reproducible assays for DNA-PK–driven pathways. This guide distills advanced experimental workflows, troubleshooting strategies, and key translational applications, spotlighting APExBIO's high-purity inhibitor as a benchmark tool for dissecting DNA damage response.

15162 records 1/1011 page Next 12345 下5页 Last page